| Ident. | Authors (with country if any) | Title |
|---|
| 000158 (2021) |
Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte] | Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial. |
| 000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
| 000424 (2021) |
Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande] | Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. |
| 000A42 (2020) |
José Meneses Calder N [Mexique] ; Hugo Mendieta Zer N [Espagne, Mexique] ; Srivatsan Padmanabhan [États-Unis] | Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. |
| 000B52 (2020) |
Eoin Feeney [Irlande (pays)] ; Deborah Wallace [Irlande (pays)] ; Aoife Cotter [Irlande (pays)] ; Willard Tinago [Irlande (pays)] ; Cormac Mccarthy [Irlande (pays)] ; David Keane [Irlande (pays)] ; Rabia Hussain [Irlande (pays)] ; Elena Alvarez Barco [Irlande (pays)] ; Peter Doran [Irlande (pays)] ; Patrick Mallon [Irlande (pays)] | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. |
| 000B55 (2020) |
Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie] | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
| 000B59 (2020) |
Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne] | Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. |
| 000C41 (2020) |
Prasan Kumar Panda [Inde] ; Arkapal Bandyopadhyay [Inde] ; Budha Charan Singh [Inde] ; Bikram Moirangthem [Inde] ; Gaurav Chikara [Inde] ; Sarama Saha [Inde] ; Yogesh Arvind Bahurupi [Inde] | Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. |
| 000C42 (2020) |
Ehsan Sekhavati [Iran] ; Fatemeh Jafari [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Saeidreza Jamalimoghadamsiahkali [Iran] ; Sara Sadr [Iran] ; Mohammad Tabarestani [Iran] ; Mohammad Pirhayati [Iran] ; Abolfazl Zendehdel [Iran] ; Navid Manafi [Iran] ; Mahboubeh Hajiabdolbaghi [Iran] ; Zahra Ahmadinejad [Iran] ; Hamid Emadi Kouchak [Iran] ; Sirous Jafari [Iran] ; Hosein Khalili [Iran] ; Mohamadreza Salehi [Iran] ; Arash Seifi [Iran] ; Fereshteh Shahmari Golestan [Iran] ; Fereshteh Ghiasvand [Iran] | Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. |
| 000C43 (2020) |
Ashkan Emadi [États-Unis] ; Joel V. Chua [États-Unis] ; Rohit Talwani [États-Unis] ; S Ren M. Bentzen [États-Unis] ; John Baddley [États-Unis] | Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. |
| 000D97 (2020) |
Florence Ader [France] | Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. |
| 000D98 (2020) |
Julie K. Wright [Canada] ; Darrell H S. Tan [Canada] ; Sharon L. Walmsley [Canada] ; Jennifer Hulme [Canada] ; Erin O'Connor [Canada] ; Carolyn Snider [Canada] ; Ivy Cheng [Canada] ; Adrienne K. Chan [Canada] ; Bjug Borgundvaag [Canada] ; Shelley Mcleod [Canada] ; Michael H. Gollob [Canada] ; Rosemarie J. Clarke [Canada] ; Linda Dresser [Canada] ; Fatima Haji [Canada] ; Tony Mazzulli [Canada] ; Samira Mubareka [Canada] ; Peter Jüni [Canada] ; Dominic Lee [Canada] ; George Tomlinson [Canada] ; Kevin C. Kain [Canada] ; Megan Landes [Canada] | Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. |
| 000E11 (2020) |
Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Rasmus Dahlin Bojesen [Danemark] ; Therese Sophie Lapperre [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Kjell Erik Julius H Kansson [Danemark] ; Andrea Browatzki [Danemark] ; Casper Tidemansen [Danemark] ; Jon Torgny Wilcke [Danemark] ; Julie Janner [Danemark] ; Vibeke Gottlieb [Danemark] ; Howraman Meteran [Danemark] ; Celeste Porsbjerg [Danemark] ; Birgitte Lindegaard Madsen [Danemark] ; Mia Moberg [Danemark] ; Lars Pedersen [Danemark] ; Thomas Lars Benfield [Danemark] ; Jens Dilling Lundgren [Danemark] ; Filip Krag Knop [Danemark] ; Tor Biering-S Rensen [Danemark] ; Muzhda Ghanizada [Danemark] ; Tine Peick Sonne [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Sidse Graff Jensen [Danemark] ; Daniel Bech Rasmussen [Danemark] ; Eva Br Ndum [Danemark] ; Oliver Djurhuus Tupper [Danemark] ; Susanne Wiemann S Rensen [Danemark] ; Gitte Alstrup [Danemark] ; Christian Borbjerg Laursen [Danemark] ; Ulla Weinrich M Ller [Danemark] ; Asger Sverrild [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark] | Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. |
| 000E94 (2020) |
Miriam Saiz-Rodríguez [Espagne] ; Teresa Pe A [Espagne] ; Lourdes Lázaro [Espagne] ; Ángel González [Espagne] ; Andrés Martínez [Espagne] ; José A. Cordero [Espagne] ; Juan T. Vicente [Espagne] ; Fernando Richard [Espagne] ; María Jesús Coma [Espagne] ; Martín De Frutos [Espagne] ; Jorge Labrador [Espagne] ; Ana Pueyo [Espagne] | Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial. |
| 000F27 (2020) |
Magnus Nakrem Lyngbakken [Norvège] ; Jan-Erik Berdal [Norvège] ; Arne Eskesen [Norvège] ; Dag Kvale [Norvège] ; Inge Christoffer Olsen [Norvège] ; Anbj Rg Rangberg [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Torbj Rn Omland [Norvège] ; Helge R Sj [Norvège] ; Olav Dalgard [Norvège] | Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. |
| 000F98 (2020) |
| Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. |
| 001090 (2020) |
Felicitas Stoll [Allemagne] ; Antje Blank [Allemagne] ; Gerd Mikus [Allemagne] ; David Czock [Allemagne] ; Kathrin I. Foerster [Allemagne] ; Simon Hermann [Allemagne] ; Katja H U Ler [Allemagne] ; Amin Muhareb [Allemagne] ; Simone Hummler [Allemagne] ; Johanna Weiss [Allemagne] ; Jürgen Burhenne [Allemagne] ; Walter E. Haefeli [Allemagne] | Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial. |
| 001168 (2020) |
Wei Tang [République populaire de Chine] ; Zhujun Cao [République populaire de Chine] ; Mingfeng Han [République populaire de Chine] ; Zhengyan Wang [République populaire de Chine] ; Junwen Chen [République populaire de Chine] ; Wenjin Sun [République populaire de Chine] ; Yaojie Wu [République populaire de Chine] ; Wei Xiao [République populaire de Chine] ; Shengyong Liu [République populaire de Chine] ; Erzhen Chen [République populaire de Chine] ; Wei Chen [République populaire de Chine] ; Xiongbiao Wang [République populaire de Chine] ; Jiuyong Yang [République populaire de Chine] ; Jun Lin [République populaire de Chine] ; Qingxia Zhao [République populaire de Chine] ; Youqin Yan [République populaire de Chine] ; Zhibin Xie [Oman] ; Dan Li [République populaire de Chine] ; Yaofeng Yang [République populaire de Chine] ; Leshan Liu [République populaire de Chine] ; Jieming Qu [République populaire de Chine] ; Guang Ning [République populaire de Chine] ; Guochao Shi [République populaire de Chine] ; Qing Xie [Oman] | Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. |
| 001195 (2020) |
Raquel González [Espagne, Mozambique] ; Laura García-Otero [Espagne, Mozambique] ; Clara Pons-Duran [Espagne] ; Elena Marbán-Castro [Espagne] ; Anna Goncé [Espagne] ; Elisa Llurba [Espagne] ; Maria Del Mar Gil [Espagne] ; Miguel Ngel Rodríguez-Zambrano [Espagne] ; Haily Chen [Espagne] ; Máximo Ramírez [Espagne] ; Azucena Bardají [Espagne, Mozambique] ; Clara Menendez [Espagne, Mozambique] | Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. |
| 001349 (2020) |
Ruanne V. Barnabas [États-Unis] ; Elizabeth Brown [États-Unis] ; Anna Bershteyn [États-Unis] ; R Scott Miller [États-Unis] ; Mark Wener [États-Unis] ; Connie Celum [États-Unis] ; Anna Wald [États-Unis] ; Helen Chu [États-Unis] ; David Wesche [États-Unis] ; Jared M. Baeten [États-Unis] | Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. |
| 001367 (2020) |
Reihaneh Pirjani [Iran] ; Tahereh Soori [Iran] ; Ahmad Reza Dehpour [Iran] ; Mahdi Sepidarkish [Iran] ; Ashraf Moini [Iran] ; Arshia Shizarpour [Iran] ; Razieh Mohammad Jafari [Iran] | Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial. |
